357
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Dexamethasone as an anti-cancer or hepatotoxic

, , , &
Pages 161-171 | Received 19 Feb 2022, Accepted 19 Jul 2022, Published online: 08 Aug 2022

References

  • Ahmadian E, Eftekhari A, Babaei H, Nayebi AM, Eghbal MA. 2017. Anti-cancer effects of citalopram on hepatocellular carcinoma cells occur via cytochrome C release and the activation of NF-kB. Anti-Cancer Agents Med Chem. 17(11):1570–1577.
  • Almeida M, Han L, Ambrogini E, Weinstein RS, Manolagas SC. 2011. Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts. Cell Biol. 286(52):44326–44335.
  • Aoki S, Morita M, Hirao T, Yamaguchi M, Shiratori R, Kikuya M, Chibana H, Ito K. 2017. Shift in energy metabolism caused by glucocorticoids enhances the effect of cytotoxic anti-cancer drugs against acute lymphoblastic leukemia cells. Oncotarget. 8(55):94271–94285.
  • Ashari S, Karami M, Shokrzadeh M, Ghandadi M, Ghassemi-Barghi N, Dashti A, Ranaee M, Mohammadi H. 2020. The implication of mitochondrial dysfunction and mitochondrial oxidative damage in di (2-ethylhexyl) phthalate induced nephrotoxicity in both in vivo and in vitro models. Toxicol Mech Methods. 30(6):427–437.
  • Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72(1–2):248–254.
  • Bray PJ, Cotton RG. 2003. Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat. 21(6):557–568.
  • Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR, O’Connell M, Shepherd FA, Johnson BE. 2001. Twenty-two years of phase III trials for patients with advanced non–small-cell lung cancer: sobering results. JCO. 19(6):1734–1742.
  • Cantiello M, Giantin M, Carletti M, Lopparelli RM, Capolongo F, Lasserre F, Bollo E, Nebbia C, Martin PGP, Pineau T, et al. 2009. Effects of dexamethasone, administered for growth promoting purposes, upon the hepatic cytochrome P450 3A expression in the veal calf. Biochem Pharmacol. 77(3):451–463.
  • Che J, Liu M, Lv H. 2022. Dexmedetomidine disrupts esophagus cancer tumorigenesis by modulating circ_0003340/miR-198/HMGA2 axis. Anticancer Drugs. 33(5):448–458.
  • Circu ML, Aw TY. 2010. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 48(6):749–762.
  • de Lemos JA, McGuire DK, Drazner MH. 2003. B-type natriuretic peptide in cardiovascular disease. Lancet. 362(9380):316–322.
  • De Martin E, Michot J-M, Rosmorduc O, Guettier C, Samuel D. 2020. Liver toxicity as a limiting factor to the increasing use of immune check point inhibitors. JHEP Rep. 2(6):100170.
  • Feng Y-L, Tang X-L. 2014. Effect of glucocorticoid-induced oxidative stress on the expression of Cbfa1. Chem Biol Interact. 207:26–31.
  • Fouad AA, Jresat I. 2012. Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity. Environ Toxicol Pharmacol. 33(2):158–167.
  • Frei E, Karon M, Levin RH, Freireich EJ, Taylor RJ, Hananian J, Selawry O, Holland JF, Hoogstraten B, Wolman IJ, et al. 1965. The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood. 26(5):642–656.
  • Hassani M, Ghassemi-Barghi N, Modanloo M, Mohammadpour A, Shokrzadeh M. 2019. Cytotoxic effects of duloxetine on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arq Gastroenterol. 56(4):372–376.
  • Hofmann J, Kaiser U, Maasberg M, Havemann K. 1995. Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. Eur J Cancer. 31(12):2053–2058.
  • Hulleman E, Kazemier KM, Holleman A, Van der Weele DJ, Rudin CM, Broekhuis MJ, Evans WE, Pieters R, Den Boer ML. 2009. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood J Am Soc Hematol. 113(9):2014–2021.
  • Huss JM, Kasper CB. 1998. Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression. J Biol Chem. 273(26):16155–16162.
  • Jackson ER, Kilroy C, Joslin DL, Schomaker SJ, Pruimboom-Brees I, Amacher DE. 2008. The early effects of short-term dexamethasone administration on hepatic and serum alanine aminotransferase in the rat. Drug Chem Toxicol. 31(4):427–445.
  • Jiang Q, Yin J, Chen J, Ma X, Wu M, Liu G, Yao K, Tan B, Yin Y. 2020. Mitochondria-targeted antioxidants: a step towards disease treatment. Oxid Med Cell Longevity. 2020:1–18.
  • Kaup B, Schindler I, Knüpfer H, Schlenzka A, Preiss R, Knüpfer MM. 2001. Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J Neurooncol. 51(2):105–110.
  • Kawamura A, Tamaki N, Kokunai T. 1998. Effect of dexamethasone on cell proliferation of neuroepithelial tumor cell lines. Neurol Med Chir. 38(10):633–640.
  • Littarru GP, Tiano L. 2007. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol. 37(1):31–37.
  • Lu Y-S, Lien H-C, Yeh P-Y, Yeh K-H, Kuo M-L, Kuo S-H, Cheng A-L. 2005. Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors. World J Gastroenterol. 11(40):6373–6380.
  • Luan G, Li G, Ma X, Jin Y, Hu N, Li J, Wang Z, Wang H. 1982. Dexamethasone-induced mitochondrial dysfunction and insulin resistance-study in 3T3-L1 adipocytes and mitochondria isolated from mouse liver. Molecules. 24(10):2019.
  • Mattern J, Büchler MW, Herr I. 2007. Cell cycle arrest by glucocorticoids may protect normal tissue and solid tumors from cancer therapy. Cancer Biol Ther. 6(9):1341–1350.
  • Mealey J, Chen TT, Schanz GP. 1971. Effects of dexamethasone and methylprednisolone on cell cultures of human glioblastomas. J Neurosurg. 34(3):324–334.
  • Mikiewicz M, Otrocka-Domagała I, Paździor-Czapula K, Rotkiewicz T. 2017. Influence of long-term, high-dose dexamethasone administration on proliferation and apoptosis in porcine hepatocytes. Res Vet Sci. 112:141–148.
  • Modir M, Daryanoosh F, Tanideh N, Mohamadi M, Firouzmand H. 2014. The effects of short and middle times aerobic exercise with high intensities on ingredients antioxidant in female Sprague Dawley rats. Med J Mashhad Univ Med Sci. 57(3):587–595.
  • Moore K, Roberts LJ. 1998. Measurement of lipid peroxidation. Free Radic Res. 28(6):659–671.
  • Motafeghi F, Mortazavi P, Mahdavi M, Shokrzadeh M. 2022. Cellular effects of epsilon toxin on the cell viability and oxidative stress of normal and lung cancer cells. Microb Pathog. 169:105649.
  • Motafeghi F, Mortazavi P, Salman Mahiny AH, Abtahi MM, Shokrzadeh M. 2022. The role of ginger’s extract and N-acetylcysteine against docetaxel-induced oxidative stress and genetic disorder. Drug Chem Toxicol. 46:1–8.
  • Portakal O, Özkaya Ö, Erden i̇nal M, Bozan B, Koşan M, Sayek I. 2000. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem. 33(4):279–284.
  • Qiu Z, Lin A, Li K, Lin W, Wang Q, Wei T, Zhu W, Luo P, Zhang J. 2019. A novel mutation panel for predicting etoposide resistance in small-cell lung cancer. DDDT. 13:2021–2041.
  • Rauscher F, Sanders R, Watkins J. 2001. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol. 15(1):41–46.
  • Rutz HP. 2002. Effects of corticosteroid use on treatment of solid tumours. Lancet. 360(9349):1969–1970.
  • Rutz HP, Herr I. 2004. Interference of glucocorticoids with apoptosis signaling and host-tumor interactions. Cancer Biol Ther. 3(8):715–718.
  • Sadeghzadeh F, Mehranjani MS, Mahmoodi M. 2019. Vitamin C ameliorates the adverse effects of dexamethasone on sperm motility, testosterone level, and spermatogenesis indexes in mice. Hum Exp Toxicol. 38(4):409–418.
  • Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. 2004. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ. 11(S1):S45–S55.
  • Shaki F, Teymoori M, Motafeghi FS, Hemmati N, Arab-Nozari M. 2021. L-arginine ameliorated mitochondrial oxidative damage induced by sub-chronic exposure to cadmium in mice kidney. PBR;7:79–86.
  • Shokrzadeh M, Etebari M, Ghassemi-Barghi N. 2020. An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress. Toxicol In Vitro. 66:104864.
  • Shokrzadeh M, Ghassemi-Barghi N. 2018. Antioxidant and genoprotective effects of amifostine against irinotecan toxicity in human hepatoma cells. Int J Cancer Res Ther. 3(1):1–5.
  • Shokrzadeh M, Mortazavi P, Karimi E, NasirOghli B, Shokrzadeh S, Motafeghi F. 2021. Evaluation of the role of vitamin C and melatonin on the genetic disorder of human blood lymphocytes in the presence of vincristine and permethrin. Tabari Biomed Stud Res J. 3(3):21–30.
  • Shokrzadeh M, Mortazavi P, Moghadami A, Khayambashi B, Motafeghi F. 2021. Synergistic antiproliferative and anticancer activity of carotenoid lutein or coenzyme Q10 in combination with doxorubicin on the MCF7 cell line. Appl Vitro Toxicol. 7(4):167–174.
  • Silva EJR, Vendramini V, Restelli A, Bertolla RP, Kempinas WG, Avellar MCW. 2014. Impact of adrenalectomy and dexamethasone treatment on testicular morphology and sperm parameters in rats: insights into the adrenal control of male reproduction. Andrology. 2(6):835–846.
  • Sommer P, Ray DW. 2008. Novel therapeutic agents targeting the glucocorticoid receptor for inflammation and cancer. Curr Opin Investig Drugs. 9(10):1070–1077.
  • Sutken E, Aral E, Ozdemir F, Uslu S, Alatas O, Colak O. 2007. Protective role of melatonin and coenzyme Q10 in ochratoxin A toxicity in rat liver and kidney. Int J Toxicol. 26(1):81–87.
  • Valipour M, Naderi N, Heidarli E, Shaki F, Motafeghi F, Talebpour Amiri F, Emami S, Irannejad H. 2021. Design, synthesis and biological evaluation of naphthalene-derived (arylalkyl)azoles containing heterocyclic linkers as new anticonvulsants: a comprehensive in silico, in vitro, and in vivo study. Eur J Pharm Sci. 166:105974.
  • Viktorsson K, De Petris L, Lewensohn R. 2005. The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun. 331(3):868–880.
  • Wang L, Li Q, Yan H, Jiao G, Wang H, Chi H, Zhou H, Chen L, Shan Y, Chen Y. 2020. Resveratrol protects osteoblasts against dexamethasone-induced cytotoxicity through activation of AMP-activated protein kinase. Drug Des Dev Ther. 14:4451–4463.
  • Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et al. 2013. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41(Database issue):D955–D961.
  • Yi J, Zhu R, Wu J, Wu J, Xia W, Zhu L, Jiang W, Xiang S, Tan Z. 2016. In vivo protective effect of betulinic acid on dexamethasone induced thymocyte apoptosis by reducing oxidative stress. Pharmacol Rep. 68(1):95–100.
  • Zhang F, Xu Z, Gao J, Xu B, Deng Y. 2008. In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol Pharmacol. 26(2):232–236.
  • Zhu L, Yi X, Zhao J, Yuan Z, Wen L, Pozniak B, Obminska-Mrukowicz B, Tian Y, Tan Z, Wu J, et al. 2018. Betulinic acid attenuates dexamethasone-induced oxidative damage through the JNK-P38 MAPK signaling pathway in mice. Biomed Pharmacother. 103:499–508.
  • Zibera C, Gibelli N, Butti G, Pedrazzoli P, Carbone M, Magrassi L, Robustelli della Cuna G. 1992. Proliferative effect of dexamethasone on a human glioblastoma cell line (HU 197) is mediated by glucocorticoid receptors. Anticancer Res. 12(5):1571–1574.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.